| Literature DB >> 26983349 |
Marc Miravitlles1, Heinrich Worth2, Juan José Soler-Cataluña3, David Price4, Fernando De Benedetto5, Nicolas Roche6, Nina S Godtfredsen7, Thys van der Molen8, Claes-Göran Löfdahl9, Laura Padullés10, Anna Ribera11.
Abstract
This observational study assessed the relationship between nighttime, early-morning and daytime chronic obstructive pulmonary disease (COPD) symptoms and exacerbations and healthcare resource use. COPD symptoms were assessed at baseline in patients with stable COPD using a standardised questionnaire during routine clinical visits. Information was recorded on exacerbations and healthcare resource use during the year before baseline and during a 6-month follow-up period. The main objective of the analysis was to determine the predictive nature of current symptoms for future exacerbations and healthcare resource use. 727 patients were eligible (65.8% male, mean age: 67.2 years, % predicted forced expiratory volume in 1 second: 52.8%); 698 patients (96.0%) provided information after 6 months. Symptoms in any part of the day were associated with a prior history of exacerbations (all p < 0.05) and nighttime and early-morning symptoms were associated with the frequency of primary care visits in the year before baseline (both p < 0.01). During follow-up, patients with baseline symptoms during any part of the 24-hour day had more exacerbations than patients with no symptoms in each period (all p < 0.05); there was also an association between 24-hour symptoms and the frequency of primary care visits (all p ≤ 0.01). Although there was a significant association between early-morning and daytime symptoms and exacerbations during follow-up (both p < 0.01), significance was not maintained when adjusted for potential confounders. Prior exacerbations were most strongly associated with future risk of exacerbation. The results suggest 24-hour COPD symptoms do not independently predict future exacerbation risk.Entities:
Keywords: Cohort; exacerbation risk; morning symptoms; nighttime symptoms; prospective; retrospective
Mesh:
Year: 2016 PMID: 26983349 DOI: 10.3109/15412555.2016.1150447
Source DB: PubMed Journal: COPD ISSN: 1541-2563 Impact factor: 2.409